We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current I1NC34 market cap is 30.62B. The company's latest EPS is USD 2.6666 and P/E is 19.89.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 810.04M | 955.16M | 917.97M | 1.01B | 881.91M |
| Operating Income | 24.77M | 193.78M | 214.71M | 217.33M | 91.44M |
| Net Income | 21.7M | 203.55M | 171.27M | 201.08M | 169.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.16B | 2.67B | 2.99B | 3.39B | 3.7B |
| Operating Income | 402.01M | -263.68M | 585.78M | 579.44M | 649.73M |
| Net Income | 446.91M | -295.7M | 948.58M | 340.66M | 597.6M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.8B | 6.21B | 6.39B | 6.78B | 7.14B |
| Total Liabilities | 1.34B | 1.47B | 1.46B | 1.59B | 1.74B |
| Total Equity | 4.46B | 4.74B | 4.93B | 5.19B | 5.39B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.43B | 3.56B | 4.93B | 5.84B | 6.78B |
| Total Liabilities | 828.34M | 949.65M | 1.16B | 1.47B | 1.59B |
| Total Equity | 2.6B | 2.61B | 3.77B | 4.37B | 5.19B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -105.6M | 200.92M | 348.76M | 496.49M | 218.81M |
| Investing | -28.56M | -35.99M | -53.18M | -207.68M | -73.11M |
| Financing | 4.01M | 16.88M | -20.38M | -20.03M | -12.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 710.66M | -124.6M | 749.49M | 969.94M | 496.49M |
| Investing | -87.45M | -269M | -207.7M | -78.54M | -207.68M |
| Financing | 45.71M | 71.71M | 6.18M | -794k | -20.03M |
| Market Cap | 30.62B |
| Price to Earnings Ratio | 19.89 |
| Price to Sales Ratio | 3.22 |
| Price to Cash Ratio | 3.7 |
| Price to Book Ratio | 2.29 |
| Dividend Yield | - |
| Shares Outstanding | 224.11M |
| Average Volume (1 week) | 10 |
| Average Volume (1 Month) | 10 |
| 52 Week Change | -12.04% |
| 52 Week High | 160.02 |
| 52 Week Low | 135.90 |
| Spread (Intraday) | 0.56 (0.41%) |
| Company Name | Incyte Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.incyte.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
